Singh steps down as Daiichi takes greater control of Ranbaxy
Ranbaxy CEO Malvinder Singh has left the troubled drugmaker just seven months into a five year contract awarded by Japanese owner DaiiChi Sankyo.
Ranbaxy CEO Malvinder Singh has left the troubled drugmaker just seven months into a five year contract awarded by Japanese owner DaiiChi Sankyo.
Contracting giant Patheon has started legal action to restrict the voting rights of private equity group JLL Holdings, in the latest move of an increasingly acrimonious takeover battle.
Stiffer penalties for counterfeiters could be counterproductive in less developed countries (LDC) and “entrench the corrupt symbiotic relationship between counterfeiters, lawmakers and officials”, according to a report
US CRO Ockham Development group will start providing customers with data capture and analysis solutions developed by etrials under a new, five year licensing agreement.
Outsourcing-Pharma provides its latest round up of movements in the pharmaceutical outsourcing sector, including an executive reshuffle at PPD that caused share price to dip.
Wacker has brought its expanded cyclodextrin facility online following its $21m (€15m) expansion, which has significantly increased capacity in response to growing demand for the excipient.